Faculty

Anna Wald

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Professor, Laboratory Medicine and Pathology

206-520-4340
annawald@uw.edu

Education

MD Medicine, Mt Sinai School of Medicine, 1985
MPH Epidemiology, University of Washington, 1994
BA Comparative Religion, Wesleyan University, 1979

Contact

206-520-4340
annawald@uw.edu

University of Washington
Box 359928
325 9th Avenue
Seattle, WA 98104

Research Interests

Dr. Wald's current research centers on the epidemiology and natural history of chronic viral infections in immunocompetent and immunocompromised hosts. She is also working on clinical trials of antiviral therapeutics and prophylactic and therapeutic vaccines for viral pathogens. Other ongoing studies address the interaction between sexually transmitted infections and microbiome.

Recent Publications (PubMed)

T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity.
(2021 Mar 22)
medRxiv
Elyanow R, Snyder TM, Dalai SC, Gittelman RM, Boonyaratanakornkit J, Wald A, Selke S, Wener MH, Morishima C, Greninger AL, Holbrook MR, Kaplan IM, Zahid HJ, Carlson JM, Baldo L, Manley T, Robins HS, Koelle DM

B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin.
(2021 May 3)
J Clin Invest 131(9):
Ford ES, Sholukh AM, Boytz R, Carmack SS, Klock A, Phasouk K, Shao D, Rossenkhan R, Edlefsen PT, Peng T, Johnston C, Wald A, Zhu J, Corey L

Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial.
(2021 Mar)
EClinicalMedicine 33(): 100773
Johnston C, Brown ER, Stewart J, Karita HCS, Kissinger PJ, Dwyer J, Hosek S, Oyedele T, Paasche-Orlow MK, Paolino K, Heller KB, Leingang H, Haugen HS, Dong TQ, Bershteyn A, Sridhar AR, Poole J, Noseworthy PA, Ackerman MJ, Morrison S, Greninger AL, Huang ML, Jerome KR, Wener MH, Wald A, Schiffer JT, Celum C, Chu HY, Barnabas RV, Baeten JM, COVID-19 Early Treatment Study Team.

Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.
(2021 Mar 22)
JCI Insight 6(6):
Yu KK, Fischinger S, Smith MT, Atyeo C, Cizmeci D, Wolf CR, Layton ED, Logue JK, Aguilar MS, Shuey K, Loos C, Yu J, Franko N, Choi RY, Wald A, Barouch DH, Koelle DM, Lauffenburger D, Chu HY, Alter G, Seshadri C

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19.
(2021 Feb 22)
Sci Rep 11(1): 4290
Phan IQ, Subramanian S, Kim D, Murphy M, Pettie D, Carter L, Anishchenko I, Barrett LK, Craig J, Tillery L, Shek R, Harrington WE, Koelle DM, Wald A, Veesler D, King N, Boonyaratanakornkit J, Isoherranen N, Greninger AL, Jerome KR, Chu H, Staker B, Stewart L, Myler PJ, Van Voorhis WC

Show complete publication list